Hemarus

Hyderabad, India Founded: 2003 • Age: 23 yrs Acquired By Olam Agro
Specialty plasma derived biopharmaceuticals for bleeding disorders
Request Access

About Hemarus

Hemarus is a company based in Hyderabad (India) founded in 2003 was acquired by Olam Agro in August 2011.. The company has 68 employees as of March 31, 2024. Hemarus operates in a competitive market with competitors including Editas Medicine, GBT, LogicBio, Kedrion and Modus Therapeutics, among others.

  • Headquarter Hyderabad, India
  • Employees 68 as on 31 Mar, 2024
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Hemarus Therapeutics Limited
  • Date of Incorporation 16 Sep, 2003
  • Jurisdiction Shaikpet, Telangana, India
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $853.5 K (USD)
    -84.64
    as on Mar 31, 2022
  • Net Profit
    $-2.27 M (USD)
    -275.8
    as on Mar 31, 2022
  • EBITDA
    $-2.37 M (USD)
    -716.81
    as on Mar 31, 2022
  • Latest Funding Round
  • Investors
  • Employee Count
    68

    as on Mar 31, 2024

  • Acquired by
    Olam Agro

    (Aug 31, 2011)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Hemarus

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Hemarus

Hemarus has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Olam Agro. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Provider of farm gate sourcing-based processing and selling solutions for farmers
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Hemarus

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Hemarus

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Hemarus Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Hemarus

Hemarus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Editas Medicine, GBT, LogicBio, Kedrion and Modus Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutics for rare genetic diseases are developed using CRISPR technology.
domain founded_year HQ Location
Small molecules are developed for sickle cell disease treatment.
domain founded_year HQ Location
Viral vectors are developed for genetic and infectious disease treatments.
domain founded_year HQ Location
Plasma-derived therapies are developed for hemophilia and immune deficiencies.
domain founded_year HQ Location
Polysaccharide-based drug for Sickle Cell Disease treatment is developed.
domain founded_year HQ Location
Therapies for sickle cell disease and diabetic nephropathy are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Hemarus

Frequently Asked Questions about Hemarus

When was Hemarus founded?

Hemarus was founded in 2003.

Where is Hemarus located?

Hemarus is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

How many employees does Hemarus have?

As of Mar 31, 2024, the latest employee count at Hemarus is 68.

What is the annual revenue of Hemarus?

Annual revenue of Hemarus is $853.5K as on Mar 31, 2022.

What does Hemarus do?

Hemarus is an Indian Pharma manufacturer of plasma-derived biopharmaceuticals for bleeding disorders. Their products include human albumin, immunoglobulins, coagulation factor, fibrin sealant etc. Their plant has a capacity to process 130,000 litres of plasma annually.

Who are the top competitors of Hemarus?

Hemarus's top competitors include GBT, Editas Medicine and Kedrion.

Who are Hemarus's investors?

Hemarus has 1 investor. Key investors include Olam Agro.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available